Trials / Completed
CompletedNCT07492355
TP-3654 Food Effect Study
A Phase 1 Randomized Study in Healthy Adult Participants to Assess the Relative Bioavailability of and Effect of Food on TP-3654 Capsule Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Sumitomo Pharma America, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TP-3654 | capsule, oral administered |
Timeline
- Start date
- 2024-03-04
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
- First posted
- 2026-03-25
- Last updated
- 2026-03-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07492355. Inclusion in this directory is not an endorsement.